Show simple item record

The Evaluation of Bone Marrow Suppression and Secondary Malignancy Risk after Radioiodine Treatment in Patients with Thyroid Cancer after 10 Years Follow Up

dc.contributor.authorAsa, S.
dc.contributor.authorSonmezoglu, K.
dc.contributor.authorSayman, H.
dc.contributor.authorBesli, R. Uslu
dc.contributor.authorSager, S.
dc.contributor.authorToplutas, K.
dc.contributor.authorKhosroshahi, S.
dc.contributor.authorUslu, I.
dc.date.accessioned2021-03-03T08:04:25Z
dc.date.available2021-03-03T08:04:25Z
dc.identifier.citationToplutas K., Sager S., Besli R. U. , Asa S., Khosroshahi S., Sayman H., Uslu I., Sonmezoglu K., "The Evaluation of Bone Marrow Suppression and Secondary Malignancy Risk after Radioiodine Treatment in Patients with Thyroid Cancer after 10 Years Follow Up", 32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, İspanya, 12 - 16 Ekim 2019, cilt.46
dc.identifier.othervv_1032021
dc.identifier.otherav_158c352e-c72d-436c-af80-9e3ab01c9c38
dc.identifier.urihttp://hdl.handle.net/20.500.12627/19854
dc.language.isoeng
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNükleer Tıp
dc.titleThe Evaluation of Bone Marrow Suppression and Secondary Malignancy Risk after Radioiodine Treatment in Patients with Thyroid Cancer after 10 Years Follow Up
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume46
dc.contributor.firstauthorID157361


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record